new-recommended-broker-banner new-recommended-broker-banner

Symphony Share Price Surges After Presenting Impressive Antiviral Gear Results

Updated: 30 Nov 2020

Shares of Symphony Environmental Technologies PLC (LON: SYM) soared 23.8% today after the company presented an impressive set of results for its antiviral gloves and masks.

In particular, the d2pAM glove showed a 99.99% virus-reduction after only one hour of contact, the data shows. Similarly, the facemask showed a 99% virus-reduction after an hour and 99.9% after two hours.

“These test results are a significant step forward in our global marketing campaign to promote the importance of using our d2p technology in these everyday essential products,” Symphony chief executive, Michael Laurier said.

new-recommended-broker-banner

“We believe this is a major breakthrough in the fight against COVID. These masks and gloves will provide essential additional protection for everyone, especially for staff, patients, and visitors in a hospital or care-home environment.”

Symphony used the Laboratory of Virology at the University of Campinas in Brazil for testing its gear against the family of viruses, namely SARS-CoV-1, SARS-CoV-2/COVID-19 and MERS.

Symphony share price gains on impressive Covid-19 gear test results November 2020

Symphony share price initially skyrocketed nearly 24% to hit a one-month high at 26p. The price action now trades at 22.6p, up 7.14%.

PEOPLE WHO READ THIS ALSO VIEWED:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .